最後更新 2024-05-10 07:27:06 (UTC+8)

基本分析

透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。

季營收趨勢 tooltip

季節調整季營收
季增率

-0.6%


截至2024-03-31

基本資料

個股的基本資料,以及所屬的類股和產業。

公司介紹

業務介紹

麥可森公司在美國和國際上提供醫療保健服務。它通過四個部門運營:美國藥品、國際、醫療手術解決方案和處方技術解決方案(RxTS)。美國藥品部門分銷品牌、仿製、特殊、生物類似和非處方藥品以及其他醫療相關產品。該部門還為基於社區的腫瘤學和其他專科診所提供實踐管理、技術、臨床支持和業務解決方案;並提供咨詢、外包、技術和其他服務,以及向藥房銷售財務、運營和臨床解決方案。國際部門在13個歐洲國家和加拿大為批發、機構和零售客戶提供分銷和服務。醫療手術解決方案部門為醫療保健提供者提供醫療手術用品分銷、物流和其他服務。RxTS部門為生物製藥和生命科學合作夥伴以及患者提供解決患者在整個治療過程中的藥物挑戰的服務;連接藥房、提供者、支付者和生物製藥公司,提供創新的訪問和依從性解決方案;並提供第三方物流和批發分銷支持解決方案。麥可森公司成立於1833年,總部位於德克薩斯州歐文市。

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

所屬產業

所屬類股
Healthcare
所屬產業
Medical - Distribution

警語

1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整,需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

warning